Fundamentals of HIV Medicine 2021 CME Edition

The essential work in HIV for providers and pharmacists, updated for 2021.

Includes CME access code for 2021 AAHIVS, AAHIVP, or AAHIVE study materials and accreditation!

An end-to-end clinical resource for the treatment of individuals with HIV/AIDS, Fundamentals of HIV Medicine has served as a key resource for clinicians preventing and treating HIV for over a decade. Now updated for 2021, Fundamentals of HIV Medicine 2021 offers state-of-the-art continuing education for physicians, pharmacists, nurse practitioners, nurses, and other professionals working in the care of HIV patients.

With this volume, practitioners will have immediate, indexed access to the most updated science, research, and guidelines related to all aspects of HIV care and prevention. This revised edition features key clinical updates across classic domains of HIV medicine along with recent research in HIV medicine including HIV workforce strains and PrEP, newly emerging antiretroviral treatment options, and the evolving effects of COVID-19 on HIV care.

Embodying the American Academy of HIV Medicine's commitment to excellence in the care of seropositive patients, Fundamentals of HIV Medicine 2021 is a must-have for health professionals across HIV care, treatment, and prevention.

Note: This edition includes a login for online CME questions and accreditation

About the Editor in Chief:

W. David Hardy, MD, currently serves as Adjunct Professor of Medicine at Johns Hopkins University School of Medicine and lives in Washington, D.C. His previous professional experience includes serving as Senior Director of Research at Whitman-Walker Health in D.C. (2015-2018), Chief Medical Officer of Calimmune, a translational science company investigating gene-modified cellular therapies as a potential cure for HIV (2013-2015) and Director of the Division of Infectious Diseases at Cedars-Sinai Medical Center and Professor of Medicine at the David Geffen School of Medicine at UCLA (2002-2013).

Early in the AIDS epidemic, he completed a clinical fellowship in infectious diseases/immunology and clinical research at the UCLA School of Medicine under the direction of Dr. Michael Gottlieb, the physician who recognized and reported the first cases of AIDS. Later he also completed a laboratory fellowship in molecular retrovirology with Irvin Chen at UCLA.

Dr. Hardy has cared for persons with HIV infection since 1982 and conducted research on HIV and related diseases since 1984. Dr. Hardy currently serves as Chair of the Board of Directors of the HIV Medicine Association (HIVMA) and Chair of the Education Committee of the American Academy of HIV Medicine (AAHIVM). He has worked with several community-based organizations, including AIDS Research Alliance, Alliance for Housing and Healing, Being Alive-Empowering People with HIV/AIDS, Project Angel Food, and AIDS Project Los Angeles.

About the American Academy of HIV Medicine (AAHIVM):

The American Academy of HIV Medicine is a professional organization that supports HIV practitioners and promotes accessible, quality care for all Americans living with HIV disease. The AAHIVM membership of HIV practitioners and credentialed providers give direct care to the majority of HIV patients in the US. The Academy's HIV-focused professional certifications are the first and only credentials offered domestically and internationally to physicians, nurse practitioners, physician assistants, and pharmacists specializing in advanced level HIV care. The HIV Specialist TM (AAHIVS) credential is available to practicing frontline clinical providers, while the HIV Expert TM (AAHIVE) designation can be earned by non-practicing clinicians. The HIV Pharmacist TM (AAHIVP) certification is available to eligible HIV-specialized pharmacists.

Method of Participation and Request for Credit

Target Audience
Overall Learning Objectives
Faculty
Joint Accreditation Statement
Physician Continuing Medical Education
Continuing Pharmacy Education
Continuing Nursing Education
Disclosure of Conflicts of Interest
Disclosure of Unlabeled Use

1. Ending of the HIV Epidemic: A Plan for American Initiatives in the United States

2. Epidemiology and the Spread of HIV

3. The Origin, Evolution, and Epidemiology of HIV-1 and HIV-2

4. Mechanisms of HIV Transmission

5. HIV Transmission Prevention

6. Immunology

7. HIV Testing and Counseling

8. Laboratory Testing Strategies, Detection, and Diagnosis

9. Initial Evaluation of the Person Living with HIV: History, Physical Examination, and Laboratory Evaluation

10. Health Maintenance

11. Diversity and Health Disparities

12. Complementary and Alternative Medicine/Integrative Medicine Approaches

13. HIV Care Coordination

14. The Pharmacist's Role in HIV Care

15. Palliative Care and End of Life Support

16. Virology and Natural History of HIV

17. Scientific Basis of Antiretroviral Therapy

18. Prescribing Antiretroviral Therapy

19. The HIV Reservoir and Cure and Remission Strategies

20. Antiretroviral Resistance: Evaluation and Clinical Management

21. Antiretrovirals During and After Hospitalization, Including Bariatric Surgery

22. Solid Organ Transplantation in Persons with HIV

23. Select Topics in the Care of Women with HIV

24. Antiretroviral Therapy for Children and Newborns

25. Understanding and Managing Antineoplastic and Antiretroviral Therapy

26. Substance Use in HIV Populations

27. Caring for Older People with HIV

28. Opportunistic Infections

29. Malignancies in HIV

30. Dermatologic Complications of HIV

31. Endocrine and Metabolic Disorders

32. Non-opportunistic Infections: Respiratory Complications

33. Psychiatric Illness and Treatment in HIV Populations

34. Neurological Effects of HIV Infection

35. HIV and Hepatitis Coinfection

36. The COVID-19 Pandemic and HIV

37. Sexually Transmitted Diseases

38. Cardiovascular Disease

39. Renal Complications

40. HIV and Bone Health

41. HIV-associated Lipodystrophy and Lipoatrophy

42. Immune Reconstitution Inflammatory Syndrome (IRIS)

43. U.S. Healthcare Systems, HIV Programs, and Coverage Policy Issues

44. Legal Issues

45. Research Design and Analysis

46. Ethical Conduct of Clinical Trials, Institutional Review Boards, Informed Consent, and Financial Conflicts of Interest

Index